Condition
Bone Diseases, Endocrine
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (2)
P 1 (1)
Trial Status
Completed4
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02718885Early Phase 1CompletedPrimary
Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
NCT00377312Early Phase 1Completed
7 Day Continuous Parathyroid Hormone IV Infusion
NCT01333267Phase 1Withdrawn
One Week Comparison Study of PTH and PTHrP Infusions
NCT00785824Completed
African-American Bone Metabolism and Lactation Study
NCT00430417CompletedPrimary
Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study
Showing all 5 trials